Abstract
We report the molecular genetic abnormalities of a patient with GSD IIId presenting with progressive myopathy and cardiopathy leading to a fatal outcome. We identified two independent deletions including a 4 bp deletion (1117–1120) and a 98 bp deletion (1135–1232) in cDNA. Sequencing of the genomic DNA of the corresponding region revealed a 4 bp deletion in exon 10; however, the other 98 bp deletion corresponding to exon 11, which was deleted in cDNA, was present in genomic DNA. We therefore concluded that skipping of exon 11 occurred in the cDNA of the patient. Intron/exon boundary analysis of the skipped exon 11 revealed no mutation in the consensus splice-site sequence. If normal splicing had occurred, a stop codon would have appeared within exon 11 due to frameshift mutation. The mechanism of exon skipping observed in our patient is as yet unknown, and it is still not clear whether intraexonal mutation of the preceding exon can influence splice-site selection. It is possible that a unique exon skipping occurred, preventing the appearance of a stop codon in our patient
Similar content being viewed by others
REFERENCES
Bao Y, Dawson TL, Chen YT (1996) Human glycogen debranching enzyme gene (AGL): complete structural organization and characterization of the 5′ flanking region. Genomics 38: 155-165.
Bao Y, Yang BZ, Dawson TL Jr, et al (1997) Isolation and nucleotide sequence of human liver glycogen debranching enzyme mRNA: identification of multiple tissue-specific isoforms. Gene 197: 389-398.
Cooper TA, Mattox W (1997) The regulation of splice-site selection, and its role in human disease. Am J Hum Genet 61: 259-266.
Dietz HC, Valle D, Francomono CA, et al (1993) The skipping of constitutive exons in vivo induced by nonsense mutations. Science 259: 680-683.
DiMauro S, Hartwig GB, Hays AP (1979) Debrancher deficiency: neuromuscular disorder in five adults. Ann Neurol 5: 422-436.
DiMauro S, Tsujino S (1994) Nonlysozomal glycogenoses. In Engel AG and Franzini Armstrong C, eds. Myology, 2nd edn. New York: McGraw-Hill, 1554-1576.
Ding JH, de Barsy T, Brown BI, et al (1990) Immunoblot analysis of glycogen debranching enzyme in different subtypes of glycogen storage disease type III. J Pediatr 116: 95-100.
Fukuda T, Sugie H, Ito M, et al (1996) Nine cases of debrancher deficiency (glycogen storage disease type III) presenting with muscle weakness—study on clinicobiochemical analysis. Clin Neurol 36: 540-543.
Fukuda T, Sugie H, Ito M (2000) Novel mutations in two Japanese cases of glycogen storage disease type IIIa and a review of the literature of molecular basis of glycogen storage disease type III. J Inherit Metab Dis 23: 95-106.
Green MR (1986) Pre-mRNA splicing. Annu Rev Genet 20: 671-708.
Momoi T, Sano H, Yamanaka C, et al (1992) Glycogen storage disease type III with muscle involvement: reappraisal of phenotypic variability and prognosis. Am J Med Genet 42: 696-699.
Morisaki H, Morisaki T, Newby LK, et al (1993) Alternative splicing: a mechanism for phenotypic rescue of a common inherited defect. J Clin Invest 91: 2275-2280.
Okubo M, Aoyama Y, Murase T (1996) A novel donor splice site mutation in the glycogen debranching enzyme gene is associated with glycogen storage disease type III. Biochem Biophys Res Commun 224: 493-499.
Philips AV, Cooper TA (2000) RNA processing and human disease. Cell Mol Life Sci 57: 235-249.
Pie J, Casals N, Casale CH (1997) A nonsense mutation in the 3-hydroxy-3-methylglutaryl-CoA lyase gene produces exon skipping in two patients of different origin with 3-hydroxy-3-methylglutaryl-CoA lyase deficiency. Biochem J 323: 329-335.
Shen J, Bao Y, Liu HM, et al (1996) Mutations in exon 3 of the glycogen debranching enzyme gene are associated with glycogen storage disease type III that is differentially expressed in liver and muscle. J Clin Invest 98: 352-357.
Yang-Feng TL, Zheng K, Yu J, et al (1992) Assignment of the human glycogen debrancher gene to chromosome 1p21. Genomics 13: 931-934.
Yang BZ, Ding JH, Enghild JJ, et al (1992) Molecular cloning and nucleotide sequence of cDNA encoding human muscle glycogen debranching enzyme. J Biol Chem 267: 9294-9299.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sugie, H., Fukuda, T., Ito, M. et al. Novel exon 11 skipping mutation in a patient with glycogen storage disease type IIId. J Inherit Metab Dis 24, 535–545 (2001). https://doi.org/10.1023/A:1012459625902
Issue Date:
DOI: https://doi.org/10.1023/A:1012459625902